Literature DB >> 29258673

Acquired Resistance to Afatinib Due to T790M-Positive Squamous Progression in EGFR-Mutant Adenosquamous Lung Carcinoma.

Biagio Ricciuti1, Giulio Metro2, Marta Brambilla2, Vienna Ludovini2, Sara Baglivo2, Annamaria Siggillino2, Enrico Prosperi3, Rita Chiari2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29258673     DOI： 10.1016/j.jtho.2017.08.025

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  3 in total

1.  Retroperitoneal Metastasis, with Marked Fibrosis, of Lung Adenocarcinoma after Afatinib Treatment: An Autopsy Case Report.

Authors:  Hiroki Ota; Tomohiro Ota; Eriko Narisawa; Hideyuki Chiba; Hiroshi Nakayama; Yoko Tsukumo; Atsuhiko Sakamoto; Naoko Honma
Journal:  Intern Med       Date:  2020-07-28       Impact factor: 1.271

Review 2.  Adenosquamous carcinoma of the lung.

Authors:  Chenghui Li; Hongyang Lu
Journal:  Onco Targets Ther       Date:  2018-08-14       Impact factor: 4.147

Review 3.  Understanding Lineage Plasticity as a Path to Targeted Therapy Failure in EGFR-Mutant Non-small Cell Lung Cancer.

Authors:  Tatiana Shaurova; Letian Zhang; David W Goodrich; Pamela A Hershberger
Journal:  Front Genet       Date:  2020-03-27       Impact factor: 4.599
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.